A Phase 1, Randomized, Placebo-Controlled, Double-Blind, Study of Safety, Pharmacokinetics and Pharmacodynamics of Velusetrag in Healthy Elderly Subjects
Phase of Trial: Phase I
Latest Information Update: 30 Sep 2014
At a glance
- Drugs Velusetrag (Primary)
- Indications Alzheimer's disease; Constipation
- Focus Adverse reactions
- Sponsors Theravance
- 01 Feb 2012 Actual end date (January 2012) added as reported by ClinicalTrials.gov.
- 01 Feb 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 08 Dec 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.